XTL Biopharmaceuticals Ltd. Stock Forecast
Evaluation of XTL Biopharmaceuticals Ltd. stock downgraded after the last trading session.
(Updated on May 03, 2024)
The XTL Biopharmaceuticals Ltd. stock price gained 0.198% on the last trading day (Friday, 3rd May 2024), rising from $2.53 to $2.53. During the last trading day the stock fluctuated 0.397% from a day low at $2.52 to a day high of $2.53. The price has been going up and down for this period, and there has been a 3.69% gain for the last 2 weeks. Volume fell on the last day by -57 shares and in total, 972 shares were bought and sold for approximately $2.46 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $2.30 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 155.71% during the next 3 months and, with a 90% probability hold a price between $5.88 and $10.86 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
XTLB Signals & Forecast
There are few to no technical positive signals at the moment. The XTL Biopharmaceuticals Ltd. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $2.57. On a fall, the stock will find some support from the short-term average at $2.50. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Wednesday, April 03, 2024, and so far it has fallen -24.02%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for XTL Biopharmaceuticals Ltd. stock
XTL Biopharmaceuticals Ltd. finds support from accumulated volume at $2.47 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.0100 between high and low, or 0.397%. For the last week the stock has had daily average volatility of 3.64%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (XTLB) For The Upcoming Trading Day Of Monday 6th
For the upcoming trading day on Monday, 6th we expect XTL Biopharmaceuticals Ltd. to open at $2.53, and during the day (based on 14 day Average True Range), to move between $2.31 and $2.75, which gives a possible trading interval of +/-$0.216 (+/-8.53%) up or down from last closing price. If XTL Biopharmaceuticals Ltd. takes out the full calculated possible swing range there will be an estimated 17.06% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $2.47 (2.37%) than the resistance at $2.62 (3.56%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is XTL Biopharmaceuticals Ltd. stock A Buy?
The XTL Biopharmaceuticals Ltd. stock holds several negative signals and despite the positive trend, we believe XTL Biopharmaceuticals Ltd. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -3.613 Sell Candidate Downgraded
Predicted Opening Price for XTL Biopharmaceuticals Ltd. of Monday, May 6, 2024
| Fair opening price May 6, 2024 | Current price |
|---|---|
| $2.53 ( 0.132%) | $2.53 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for XTLB
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 2.54 | 0.264 % | |
| R2 | 2.53 | 0.113 % | ||
| R1 | 2.53 | 0.0192 % | ||
| Current price: | 2.53 | |||
| Support | S1 | 2.52 | -0.283 % | |
| S2 | 2.52 | -0.376 % | ||
| S3 | 2.52 | -0.527 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 3.07 | 21.34 % | |
| R2 | 2.81 | 11.07 % | ||
| R1 | 2.62 | 3.56 % | ||
| Current price | 2.53 | |||
| Support | S1 | 2.47 | -2.37% | |
| S2 | 2.42 | -4.35% | ||
| S3 | 2.38 | -5.93% |
FAQ
Click here for our free guide on how to buy XTL Biopharmaceuticals Ltd. Stock.
